Yukiko Iioka1, Takako Iwata2, Hideko Yamauchi2. 1. Graduate Course of Health and Social Services, Saitama Prefectural University, 820 San-Nomiya, Koshigaya-shi, Saitama, 343-8540, Japan. iioka-yukiko@spu.ac.jp. 2. Department of Breast Center, St Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Abstract
BACKGROUND: The aim was to clarify subjective symptoms and quality of life (QOL) in breast cancer patients receiving hormone therapy. METHODS: After obtaining approval from the research ethics committee, an observational study using a self-administered questionnaire was conducted at outpatient clinical oncology offices in 3 facilities that targeted breast cancer patients under the age of 50 who had been undergoing hormone therapy for less than 1 year. The study examined elements such as the breast cancer patients' basic information, symptoms, pain in daily life, QOL, and depression/anxiety. RESULTS: There were 214 valid responses. The respondents had an average age of 43.6. Of them, 100% were also treated with Tamoxifen and 30% with LH-RH agonist. There were 75% who were cognizant of side effects. Difficult symptoms that occurred with high frequency were stiff shoulders/back pain, decreased physical strength, hot flashes, and sweating. Over half the respondents were uncertain as to whether the subjective symptoms were side effects. They lost confidence in their physical strength and felt distressed over weight gain. There were 51 with a HADS anxiety score of 8 or higher, and 46 who scored 8 points or higher for depression. CONCLUSION: Breast cancer patients undergoing hormone therapy experience a variety of pains, and some also have serious psychological symptoms. Reassessing support systems to examine screening and self-care support is an issue going forward.
BACKGROUND: The aim was to clarify subjective symptoms and quality of life (QOL) in breast cancerpatients receiving hormone therapy. METHODS: After obtaining approval from the research ethics committee, an observational study using a self-administered questionnaire was conducted at outpatient clinical oncology offices in 3 facilities that targeted breast cancerpatients under the age of 50 who had been undergoing hormone therapy for less than 1 year. The study examined elements such as the breast cancerpatients' basic information, symptoms, pain in daily life, QOL, and depression/anxiety. RESULTS: There were 214 valid responses. The respondents had an average age of 43.6. Of them, 100% were also treated with Tamoxifen and 30% with LH-RH agonist. There were 75% who were cognizant of side effects. Difficult symptoms that occurred with high frequency were stiff shoulders/back pain, decreased physical strength, hot flashes, and sweating. Over half the respondents were uncertain as to whether the subjective symptoms were side effects. They lost confidence in their physical strength and felt distressed over weight gain. There were 51 with a HADS anxiety score of 8 or higher, and 46 who scored 8 points or higher for depression. CONCLUSION:Breast cancerpatients undergoing hormone therapy experience a variety of pains, and some also have serious psychological symptoms. Reassessing support systems to examine screening and self-care support is an issue going forward.
Entities:
Keywords:
Breast cancer; Hormone therapy; QOL; Symptom
Authors: Catherine M Bender; Amanda L Gentry; Adam M Brufsky; Frances E Casillo; Susan M Cohen; Meredith M Dailey; Heidi S Donovan; Jacqueline Dunbar-Jacob; Rachel C Jankowitz; Margaret Q Rosenzweig; Paula R Sherwood; Susan M Sereika Journal: Oncol Nurs Forum Date: 2014-05 Impact factor: 2.172
Authors: Gretchen Kimmick; Sara N Edmond; Hayden B Bosworth; Jeffrey Peppercorn; Paul K Marcom; Kimberly Blackwell; Francis J Keefe; Rebecca A Shelby Journal: Breast Date: 2015-07-16 Impact factor: 4.380
Authors: Emma Walker; Ana Martins; Susie Aldiss; Faith Gibson; Rachel M Taylor Journal: J Adolesc Young Adult Oncol Date: 2016-08-03 Impact factor: 2.223
Authors: Ayako Matsuda; Kenichi Inoue; Manami Momiyama; Kobayashi Kunihiko; Kaoru Kubota; Soerindra S R S Ramai; Maarten J Fischer; Judith R Kroep; Adrian A Kaptein; Kazue Yamaoka Journal: Asian Pac J Cancer Prev Date: 2022-01-01